A recent study found that doubling the dose of Copaxone resulted in a 38% drop in enhancing lesions when compared to the current 20 mg standard dose, though injection-site reactions were worse. Take two, they're small.
Link
Showing posts with label Copaxone. Show all posts
Showing posts with label Copaxone. Show all posts
Tuesday, April 17, 2007
Labels:
"multiple sclerosis",
Copaxone,
GA,
research
Subscribe to:
Posts (Atom)